Cutaneous T cell lymphoma (CTCL) is a rare type of non-Hodgkin lymphoma that develops in the T cells. Mycosis fungoides (MF) and Sézary syndrome (SS) are two types of CTCL that mainly present in the skin. However, MF and SS can also be found in the lymph nodes, viscera, and blood. Consequently, the assessment of other white blood cells in the blood, namely CD4+/CD7-, or CD4+/CD26, is important to accurately stage these syndromes. This article reflects on the presentations that took place at the European Organisation for the Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Group 2021 Congress and discusses the role of blood involvement and treatment options in CTCL.
Latest articles
All articles
9 Mins
14th
August
Recent Advancements in wAIHA
AIHA is an acquired, heterogeneous group of rare diseases with a prevalence of 17 per 100,000.1 This group includes wAIHA…
Rate this content's potential impact on patient outcomes Submit Rating Average rating / 5. Vote count: No votes so far! Be the first to rate this content.

3 Mins
25th
July
Filgrastim Prophylaxis for Neutropenia in Myelodysplasia Pre-Surgery: Case Report
Myelodysplastic syndromes are a group of disorders that affect the bone marrow, subsequently affecting the growth and relative…
Rate this content's potential impact on patient outcomes Submit Rating Average rating / 5. Vote count: No votes so far! Be the first to rate this content.